During the past decade, Poliklinika Tehelna conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Poliklinika Tehelna" are "Idiopathic Parkinson's Disease" (2 trials). Many other conditions were trialed in "Poliklinika Tehelna" in a lesser frequency.

Most popular intervention types in "Poliklinika Tehelna" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Matching Placebo" (1 trials), "Safinamide (as add-on therapy)" (1 trials) and "Safinimide 50-100 mg/day" (1 trials). Other intervention names were less common.

The vast majority of trials in "Poliklinika Tehelna" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Poliklinika Tehelna". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Poliklinika Tehelna, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Poliklinika Tehelna, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".